Literature DB >> 27540269

Predicting synergistic effects between compounds through their structural similarity and effects on transcriptomes.

Yiyi Liu1, Hongyu Zhao1,2.   

Abstract

MOTIVATION: Combinatorial therapies have been under intensive research for cancer treatment. However, due to the large number of possible combinations among candidate compounds, exhaustive screening is prohibitive. Hence, it is important to develop computational tools that can predict compound combination effects, prioritize combinations and limit the search space to facilitate and accelerate the development of combinatorial therapies.
RESULTS: In this manuscript we consider the NCI-DREAM Drug Synergy Prediction Challenge dataset to identify features informative about combination effects. Through systematic exploration of differential expression profiles after single compound treatments and comparison of molecular structures of compounds, we found that synergistic levels of combinations are statistically significantly associated with compounds' dissimilarity in structure and similarity in induced gene expression changes. These two types of features offer complementary information in predicting experimentally measured combination effects of compound pairs. Our findings offer insights on the mechanisms underlying different combination effects and may help prioritize promising combinations in the very large search space.
AVAILABILITY AND IMPLEMENTATION: The R code for the analysis is available on https://github.com/YiyiLiu1/DrugCombination CONTACT: hongyu.zhao@yale.eduSupplementary information: Supplementary data are available at Bioinformatics online.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2016        PMID: 27540269      PMCID: PMC6078170          DOI: 10.1093/bioinformatics/btw509

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.931


  26 in total

1.  Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.

Authors:  H Joensuu; P J Roberts; M Sarlomo-Rikala; L C Andersson; P Tervahartiala; D Tuveson; S Silberman; R Capdeville; S Dimitrijevic; B Druker; G D Demetri
Journal:  N Engl J Med       Date:  2001-04-05       Impact factor: 91.245

2.  Normalization of RNA-seq data using factor analysis of control genes or samples.

Authors:  Davide Risso; John Ngai; Terence P Speed; Sandrine Dudoit
Journal:  Nat Biotechnol       Date:  2014-08-24       Impact factor: 54.908

3.  Large-scale exploration and analysis of drug combinations.

Authors:  Peng Li; Chao Huang; Yingxue Fu; Jinan Wang; Ziyin Wu; Jinlong Ru; Chunli Zheng; Zihu Guo; Xuetong Chen; Wei Zhou; Wenjuan Zhang; Yan Li; Jianxin Chen; Aiping Lu; Yonghua Wang
Journal:  Bioinformatics       Date:  2015-02-08       Impact factor: 6.937

4.  Accelerating cancer therapy development: the importance of combination strategies and collaboration. Summary of an Institute of Medicine workshop.

Authors:  Patricia M LoRusso; Renzo Canetta; John A Wagner; Erin P Balogh; Sharyl J Nass; Scott A Boerner; John Hohneker
Journal:  Clin Cancer Res       Date:  2012-10-12       Impact factor: 12.531

5.  Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer.

Authors:  Charles L Vogel; Melody A Cobleigh; Debu Tripathy; John C Gutheil; Lyndsay N Harris; Louis Fehrenbacher; Dennis J Slamon; Maureen Murphy; William F Novotny; Michael Burchmore; Steven Shak; Stanford J Stewart; Michael Press
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

6.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

Review 7.  Combinatorial drug therapy for cancer in the post-genomic era.

Authors:  Bissan Al-Lazikani; Udai Banerji; Paul Workman
Journal:  Nat Biotechnol       Date:  2012-07-10       Impact factor: 54.908

8.  Systematic exploration of synergistic drug pairs.

Authors:  Murat Cokol; Hon Nian Chua; Murat Tasan; Beste Mutlu; Zohar B Weinstein; Yo Suzuki; Mehmet E Nergiz; Michael Costanzo; Anastasia Baryshnikova; Guri Giaever; Corey Nislow; Chad L Myers; Brenda J Andrews; Charles Boone; Frederick P Roth
Journal:  Mol Syst Biol       Date:  2011-11-08       Impact factor: 11.429

9.  Systematic prediction of pharmacodynamic drug-drug interactions through protein-protein-interaction network.

Authors:  Jialiang Huang; Chaoqun Niu; Christopher D Green; Lun Yang; Hongkang Mei; Jing-Dong J Han
Journal:  PLoS Comput Biol       Date:  2013-03-21       Impact factor: 4.475

10.  DrugComboRanker: drug combination discovery based on target network analysis.

Authors:  Lei Huang; Fuhai Li; Jianting Sheng; Xiaofeng Xia; Jinwen Ma; Ming Zhan; Stephen T C Wong
Journal:  Bioinformatics       Date:  2014-06-15       Impact factor: 6.937

View more
  10 in total

Review 1.  A New View of Pathway-Driven Drug Resistance in Tumor Proliferation.

Authors:  Ruth Nussinov; Chung-Jung Tsai; Hyunbum Jang
Journal:  Trends Pharmacol Sci       Date:  2017-02-27       Impact factor: 14.819

Review 2.  Network Control Models With Personalized Genomics Data for Understanding Tumor Heterogeneity in Cancer.

Authors:  Jipeng Yan; Zhuo Hu; Zong-Wei Li; Shiren Sun; Wei-Feng Guo
Journal:  Front Oncol       Date:  2022-05-31       Impact factor: 5.738

Review 3.  Representation of molecules for drug response prediction.

Authors:  Xin An; Xi Chen; Daiyao Yi; Hongyang Li; Yuanfang Guan
Journal:  Brief Bioinform       Date:  2022-01-17       Impact factor: 13.994

Review 4.  Biomolecular Network-Based Synergistic Drug Combination Discovery.

Authors:  Xiangyi Li; Guangrong Qin; Qingmin Yang; Lanming Chen; Lu Xie
Journal:  Biomed Res Int       Date:  2016-11-07       Impact factor: 3.411

5.  Natural Product Target Network Reveals Potential for Cancer Combination Therapies.

Authors:  Steven R Chamberlin; Aurora Blucher; Guanming Wu; Lynne Shinto; Gabrielle Choonoo; Molly Kulesz-Martin; Shannon McWeeney
Journal:  Front Pharmacol       Date:  2019-05-31       Impact factor: 5.810

Review 6.  An update on novel approaches for diagnosis and treatment of SARS-CoV-2 infection.

Authors:  Azadeh Safarchi; Shadma Fatima; Zahra Ayati; Fatemeh Vafaee
Journal:  Cell Biosci       Date:  2021-08-22       Impact factor: 7.133

7.  A systematic and prospectively validated approach for identifying synergistic drug combinations against malaria.

Authors:  Yasaman KalantarMotamedi; Richard T Eastman; Rajarshi Guha; Andreas Bender
Journal:  Malar J       Date:  2018-04-11       Impact factor: 2.979

8.  Bioactive Compounds of Pseudoalteromonas sp. IBRL PD4.8 Inhibit Growth of Fouling Bacteria and Attenuate Biofilms of Vibrio alginolyticus FB3.

Authors:  Nor Afifah Supardy; Darah Ibrahim; Sharifah Radziah Mat Nor; Wan Norhana Md Noordin
Journal:  Pol J Microbiol       Date:  2019

9.  Synergistic Cytotoxicity of Renieramycin M and Doxorubicin in MCF-7 Breast Cancer Cells.

Authors:  Jortan O Tun; Lilibeth A Salvador-Reyes; Michael C Velarde; Naoki Saito; Khanit Suwanborirux; Gisela P Concepcion
Journal:  Mar Drugs       Date:  2019-09-16       Impact factor: 5.118

10.  Integrative resource for network-based investigation of COVID-19 combinatorial drug repositioning and mechanism of action.

Authors:  A K M Azad; Shadma Fatima; Alexander Capraro; Shafagh A Waters; Fatemeh Vafaee
Journal:  Patterns (N Y)       Date:  2021-07-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.